Sumatriptan succinate

CAS No. 103628-48-4

Sumatriptan succinate( GR 43175C )

Catalog No. M10181 CAS No. 103628-48-4

Sumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 37 In Stock
50MG 53 In Stock
100MG 77 In Stock
200MG 105 In Stock
500MG 230 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sumatriptan succinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.
  • Description
    Sumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GR 43175C
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    103628-48-4
  • Formula Weight
    413.49
  • Molecular Formula
    C18H27N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 83 mg/mL (200.73 mM); DMSO: 83 mg/mL (200.73 mM)
  • SMILES
    OC(=O)CCC(O)=O.CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Peroutka SJ, et al. Eur J Pharmacol, 1989, 163(1), 133-136.
molnova catalog
related products
  • RG2833

    RG2833 (RGFP109), a brain-penetrant HDAC inhibitor, is with IC50 of 60 nM and 50 nM for HDAC1 and HDAC3, respectively.

  • N-Desmethylclozapine

    N-Desmethylclozapine is an antagonist of serotonin (5-HT) receptor subtype 5-HT2C (IC50: 7.1 nM). It also is an antagonist at dopamine D4 receptors an agonist at δ-opioid receptors.

  • SHP099 hydrochloride

    SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.